<div>Introduction
</div>
<div>Hi, we are Faisal Rehman and Bajuna Salehe, and we’re raising funds to launch an AI-driven early detection platform for multiple cancers—a tool We believe could save lives
</div>
<div>We live in a world where nearly 1 in 2 people will be diagnosed with cancer in their lifetime (Cancer Research UK, 2023). Despite advances in treatment, early detection remains our most powerful tool. When cancers are diagnosed at an early stage, the chances of survival increase dramatically—for example, over 90% of early-stage breast cancer patients survive compared to less than 30% when diagnosed at a late stage (American Cancer Society, 2024).
</div>
<div><br />
</div>
<div>That’s why we’re building a startup focused on AI-powered multi-cancer screening, beginning with a prototype that uses blood-based protein expression data—a less invasive and more accessible alternative to traditional biopsies.
</div>
<div><br />
</div>
<div>What Are We Building?
</div>
<div>With the rise of AI in medicine and the availability of vast genomic and proteomic datasets, our team has trained preliminary models using open biomedical databases such as TCGA (The Cancer Genome Atlas) and GTEx (Genotype-Tissue Expression Project).
</div>
<div><br />
</div>
<div>The results so far have been very promising:
</div>
<ul>
<li>We’ve developed three initial machine learning models showing high sensitivity in detecting lung, colorectal, and oesophagus cancers using protein expression data.
</li>
<li>These models are based purely on open-source data, proving the feasibility of a scalable and accessible approach.
</li>
</ul>
<div><br />
</div>
<div>The next step is to build a working prototype.
</div>
<div><br />
</div>
<div>This prototype will consist of:
</div>
<ul>
<li>A web-based interface where users (e.g., researchers, clinicians) can upload blood sample-derived expression data.
</li>
<li>An AI-powered backend, hosted securely in the cloud (AWS, DigitalOcean, or GCP), to analyse the data and return early diagnostic insights, risk probabilities, and visualisation patterns.
</li>
<li>A focus on ease of use, data privacy, and scalability for integration with healthcare platforms.
</li>
</ul>
<div><br />
</div>
<div>Why This Matters (Backed by Science)
</div>
<div>Cancer isn’t one disease—it’s over 200. The dream of detecting multiple cancers with one test is no longer science fiction. Recent breakthroughs like GRAIL's Galleri test (2022), which can detect 50+ cancers from a single blood draw, show how liquid biopsy and AI are changing the landscape. However, access and affordability remain challenges.
</div>
<div>Our mission is to develop a timely, cost-effective, open-data-based alternative that can be adapted globally.
</div>
<div><br />
</div>
<div>Research has consistently shown:
</div>
<ul>
<li>Early detection improves outcomes and reduces treatment costs (World Health Organization, 2022).
</li>
<li>AI can enhance the accuracy and reduce human error in diagnostics (Topol, Deep Medicine, 2019).
</li>
<li>Protein markers—unlike genetics ones—are directly tied to disease activity, making them especially useful in real-time diagnostics (Petricoin et al., 2004).
</li>
</ul>
<div><br />
</div>
<div>Where Will the Money Go?
</div>
<div>We’re seeking to raise £10,000, which will be allocated as follows:
</div>
<ul>
<li>One front-end developer – to design a secure and intuitive user interface (20% ~ £2,000).
</li>
<li>One back-end developer – to build and deploy the AI-powered engine that handles data preprocessing, inference, and result delivery (30% ~ £3,000).
</li>
<li>Cloud computing resources – for model deployment, scaling, and secure data handling (30% ~ £3,000).
</li>
<li>Further testing &amp; validation – ensuring our models hold up under realistic conditions and data (20% ~ £2,000).
</li>
</ul>
<div>This prototype will be the foundation for future clinical testing, regulatory review, and eventual patient-focused applications.
</div>
<div><br />
</div>
<div>How You Can Help?
</div>
<div>By supporting this campaign, you're not just funding a startup—you’re contributing to a world where people have a better chance of surviving cancer simply because it was found before symptoms even appeared.
</div>
<div><br />
</div>
<div>Whether you can give £5 or £500, every pound brings us closer to building this life-saving tool. If you can’t donate, please consider sharing this page—your voice can be just as powerful as your donation.
</div>
<div><br />
</div>
<div>Thank you for believing in the power of science, technology, and compassion.
</div>
<div><br />
</div>
<div>Together, we can detect early, act early, and live longer.
</div>
<div><br />
</div>
<div>With gratitude,
</div>
<div>Faisal Rehman &amp; Bajuna Salehe
</div>
<div>Co-Founders | OmnicareDX
</div>
<div>Website: <a href="https://www.omnicaredx.co.uk" target="_blank" rel="noreferrer noopener"><a href="https://www.omnicaredx.co.uk/" target="_blank" class="" rel="nofollow noopener noreferrer">https://www.omnicaredx.co.uk/</a></a>
</div>
<div><br />
</div>
<div>Reference
</div>
<ul>
<li>American Cancer Society. (2024). Survival rates for breast cancer. <a href="https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis/survival-rate" target="_blank" rel="noreferrer noopener"><a href="https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis/survival-rate" target="_blank" class="" rel="nofollow noopener noreferrer">https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis/survival-rate</a></a> s-for-breast-cancer.html
</li>
<li>Cancer Research UK. (2023). Cancer incidence statistics. <a href="https://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence" target="_blank" rel="noreferrer noopener"><a href="https://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence" target="_blank" class="" rel="nofollow noopener noreferrer">https://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence</a></a>
</li>
<li>GRAIL. (2022). Galleri test for early cancer detection. <a href="https://grail.com/galleri/" target="_blank" rel="noreferrer noopener"><a href="https://grail.com/galleri/" target="_blank" class="" rel="nofollow noopener noreferrer">https://grail.com/galleri/</a></a>
</li>
<li>Petricoin, E. F., et al. (2004). Clinical proteomics: Revolutionizing disease detection and management. Nature Reviews Clinical Oncology.
</li>
<li>Topol, E. (2019). Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again.
</li>
<li>World Health Organization. (2022). Cancer. <a href="https://www.who.int/news-room/fact-sheets/detail/cancer" target="_blank" rel="noreferrer noopener"><a href="https://www.who.int/news-room/fact-sheets/detail/cancer" target="_blank" class="" rel="nofollow noopener noreferrer">https://www.who.int/news-room/fact-sheets/detail/cancer</a></a>
</li>
</ul>

Anonymous

Mohamed Ally

Sahil Rehman

Donate to help detect multi-cancer early, and live longer

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

Supporter Comments Eligible Funds

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

currencyCode

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

writePath

Stream Notification

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

unclaimed charities

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

Users Receiving Braze KYC Validation Failed

Native 11.3.0 and above

Influencer - Prod

US fundraisers and US users

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

isCampaignOwner

fundHasInstagramDeepLink

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

userCurrencyCode

Localized Currency

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

Donate to help detect multi-cancer early, and live longer

Still £3,942 to go. Help us build momentum.